Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) today
announced that it will release its financial results for the first
quarter ended March 31, 2019, after the close of the financial markets
on Tuesday, April 30, 2019. Management will host a conference call on
Wednesday, May 1, 2019 at 9:00 am ET to discuss the results and business
activities.
Interested parties may participate in the call by dialing:
-
(877) 407-9753 (Domestic) or
-
(201) 493-6739 (International)
Webcast registration: Click
Here
Following the live call, a replay will be available for six months on
the Company's website, www.rmsmedicalproducts.com,
under "Investor Relations."
About RMS Medical Products
RMS Medical develops, manufactures and commercializes innovative and
easy-to-use specialty infusion solutions that improve quality of life
for patients around the world. The FREEDOM Syringe Infusion System
currently includes the FREEDOM60® and FreedomEdge®
Syringe Infusion Drivers, RMS Precision Flow Rate Tubing™ and
RMS HIgH-Flo Subcutaneous Safety Needle Sets™. These devices
are used for infusions administered in the home and alternate care
settings. For more information about RMS Medical, please visit www.rmsmedicalproducts.com.
Forward-Looking Statements
The statements contained herein may include prospects, statements of
future expectations and other forward-looking statements that are based
on management's current views and assumptions and involve known and
unknown risks and uncertainties, identified by words such as ''will”.
Actual results, performance or events may differ materially from those
expressed or implied in such forward-looking statements. RMS Medical
undertakes no obligation to update any forward-looking statements.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190422005332/en/
Copyright Business Wire 2019